Intercept Pharmaceuticals Inc (OQ:ICPT)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for ICPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Apr 9/18 Apr 9/18 Gottesdiener Keith Michael Direct Ownership Common Stock P - Open market or private purchase 1,171 $64.00
Apr 9/18 Apr 9/18 Pruzanski Mark Direct Ownership Common Stock P - Open market or private purchase 7,812 $64.00
Apr 9/18 Apr 9/18 Bradbury Daniel Direct Ownership Common Stock P - Open market or private purchase 7,812 $64.00
Apr 9/18 Apr 9/18 Genextra S.p.A. Direct Ownership Common stock, par value $0.001 per share P - Open market or private purchase 390,625 $64.00
Apr 9/18 Apr 9/18 Micheli Francesco Indirect Ownership Common stock, par value $0.001 per share P - Open market or private purchase 390,625 $64.00
Apr 9/18 Apr 5/18 Akkaraju Srinivas Indirect Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 234,375 $64.00
Feb 15/18 Feb 13/18 Sullivan Ryan T Direct Ownership Option to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 35,300  
Feb 15/18 Feb 13/18 Sullivan Ryan T Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 23,200  
Feb 22/18 Feb 5/18 Bright Lisa Direct Ownership Option to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 8,300  
Feb 22/18 Feb 5/18 Bright Lisa Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 5,500  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for ICPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Apr 9/18 Apr 9/18 Gottesdiener Keith Michael Direct Ownership Common Stock P - Open market or private purchase 1,171 $64.00
Apr 9/18 Apr 9/18 Pruzanski Mark Direct Ownership Common Stock P - Open market or private purchase 7,812 $64.00
Apr 9/18 Apr 9/18 Bradbury Daniel Direct Ownership Common Stock P - Open market or private purchase 7,812 $64.00
Apr 9/18 Apr 5/18 Akkaraju Srinivas Indirect Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 234,375 $64.00
Apr 9/18 Apr 9/18 Genextra S.p.A. Direct Ownership Common stock, par value $0.001 per share P - Open market or private purchase 390,625 $64.00
Apr 9/18 Apr 9/18 Micheli Francesco Indirect Ownership Common stock, par value $0.001 per share P - Open market or private purchase 390,625 $64.00
Feb 22/18 Feb 5/18 Bright Lisa Direct Ownership Option to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 8,300  
Feb 22/18 Feb 5/18 Bright Lisa Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 5,500  
Feb 22/18 Feb 5/18 Ford David A Direct Ownership Option to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 6,600  
Feb 22/18 Feb 5/18 Ford David A Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,300  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $ICPT

StockTwits